Adeola Y. Makinde, Ph.D.
Affiliations: | 2009 | Loma Linda University, Loma Linda, United States |
Area:
Biochemistry, Immunology, OncologyGoogle:
"Adeola Makinde"Parents
Sign in to add mentor| Daila S. Gridley | grad student | 2009 | Loma Linda University | |
| (MnTE-2-PyP and radiation in a prostate cancer model: Implications for radiotherapy.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Eke I, Aryankalayil MJ, Bylicky MA, et al. (2022) Radiotherapy alters expression of molecular targets in prostate cancer in a fractionation- and time-dependent manner. Scientific Reports. 12: 3500 |
| Coleman CN, Eke I, Makinde AY, et al. (2020) Radiation-induced adaptive response: new potential for cancer treatment. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Eke I, Makinde AY, Aryankalayil MJ, et al. (2018) Long-term Tumor Adaptation after Radiotherapy: Therapeutic Implications for Targeting Integrins in Prostate Cancer. Molecular Cancer Research : McR |
| Aryankalayil MJ, Chopra S, Makinde A, et al. (2018) Microarray analysis of miRNA expression profiles following whole body irradiation in a mouse model. Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals. 1-26 |
| Aryankalayil MJ, Chopra S, Levin J, et al. (2018) Radiation-Induced Long Noncoding RNAs in a Mouse Model after Whole-Body Irradiation. Radiation Research |
| Eke I, Makinde AY, Aryankalayil MJ, et al. (2017) Exploiting radiation-induced signaling to increase the susceptibility of resistant cancer cells to targeted drugs: AKT and mTOR inhibitors as an example. Molecular Cancer Therapeutics |
| Makinde AY, Eke I, Aryankalayil MJ, et al. (2016) Exploiting Gene Expression Kinetics in Conventional Radiotherapy, Hyperfractionation, and Hypofractionation for Targeted Therapy. Seminars in Radiation Oncology. 26: 254-60 |
| Eke I, Makinde AY, Aryankalayil MJ, et al. (2016) Comprehensive molecular tumor profiling in radiation oncology: How it could be used for precision medicine. Cancer Letters |
| Makinde AY, Eke I, Aryankalayil MJ, et al. (2015) Abstract C146: Radiation-inducible molecular targets in a human prostate cancer mouse model Molecular Cancer Therapeutics. 14 |
| Aryankalayil MJ, Makinde AY, Gameiro SR, et al. (2014) Defining molecular signature of pro-immunogenic radiotherapy targets in human prostate cancer cells. Radiation Research. 182: 139-48 |